Detalles de la búsqueda
1.
Sotorasib in KRAS p.G12C-Mutated Advanced Pancreatic Cancer.
N Engl J Med;
388(1): 33-43, 2023 01 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36546651
2.
A multicenter phase Ia study of AbGn-107, a novel antibody-drug conjugate, in patients with advanced gastrointestinal cancer.
Invest New Drugs;
42(2): 221-228, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38441850
3.
Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2 study.
Lancet Oncol;
24(5): 496-508, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37142372
4.
KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors.
N Engl J Med;
383(13): 1207-1217, 2020 09 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-32955176
5.
A Phase 3 Randomized Clinical Trial of Chemotherapy With or Without Algenpantucel-L (HyperAcute-Pancreas) Immunotherapy in Subjects With Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer.
Ann Surg;
275(1): 45-53, 2022 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33630475
6.
KRAS Mutation Variants and Co-occurring PI3K Pathway Alterations Impact Survival for Patients with Pancreatic Ductal Adenocarcinomas.
Oncologist;
27(12): 1025-1033, 2022 12 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36124727
7.
Pancreas Cancer-Associated Pain Management.
Oncologist;
26(6): e971-e982, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33885205
8.
Targeting the Tumor Stroma: the Biology and Clinical Development of Pegylated Recombinant Human Hyaluronidase (PEGPH20).
Curr Oncol Rep;
19(7): 47, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28589527
9.
A phase 1 clinical trial of ASG-5ME, a novel drug-antibody conjugate targeting SLC44A4, in patients with advanced pancreatic and gastric cancers.
Invest New Drugs;
34(3): 319-28, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26994014
10.
HER-2/neu vaccine-primed autologous T-cell infusions for the treatment of advanced stage HER-2/neu expressing cancers.
Cancer Immunol Immunother;
63(2): 101-9, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24162107
11.
Phase I Study of Elraglusib (9-ING-41), a Glycogen Synthase Kinase-3ß Inhibitor, as Monotherapy or Combined with Chemotherapy in Patients with Advanced Malignancies.
Clin Cancer Res;
30(3): 522-531, 2024 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37982822
12.
Organ Preservation and Survival by Clinical Response Grade in Patients With Rectal Cancer Treated With Total Neoadjuvant Therapy: A Secondary Analysis of the OPRA Randomized Clinical Trial.
JAMA Netw Open;
7(1): e2350903, 2024 Jan 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38194231
13.
Long-Term Results of Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy: The Randomized Phase II OPRA Trial.
J Clin Oncol;
42(5): 500-506, 2024 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37883738
14.
Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders.
J Immunother Cancer;
12(1)2024 01 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38272561
15.
New generation of ensemble-decision aliquot ranking based on simplified microfluidic components for large-capacity trapping of circulating tumor cells.
Anal Chem;
85(20): 9671-7, 2013 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24087951
16.
Safety and Outcomes of a Plasmid DNA Vaccine Encoding the ERBB2 Intracellular Domain in Patients With Advanced-Stage ERBB2-Positive Breast Cancer: A Phase 1 Nonrandomized Clinical Trial.
JAMA Oncol;
9(1): 71-78, 2023 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36326756
17.
A Phase I/II Trial of HER2 Vaccine-Primed Autologous T-Cell Infusions in Patients with Treatment Refractory HER2-Overexpressing Breast Cancer.
Clin Cancer Res;
29(17): 3362-3371, 2023 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37093223
18.
Perioperative Chemotherapy and Chemoradiotherapy for Patients With Resectable and Borderline Resectable Pancreatic Adenocarcinoma.
Pancreas;
52(5): e282-e287, 2023 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37782886
19.
Phase 1 dose-escalation study of SEA-CD40: a non-fucosylated CD40 agonist, in advanced solid tumors and lymphomas.
J Immunother Cancer;
11(6)2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37385724
20.
Use of acupuncture with acupressure in addition to standard-of-care cryotherapy to decrease chemotherapy-associated neuropathy in patients with gastrointestinal malignancies receiving oxaliplatin-based chemotherapy: Study protocol for a randomized, controlled pilot and feasibility study.
Contemp Clin Trials;
131: 107273, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37380021